(Q28281781)

2

0 references

Peter Graf

3

0 references

James C Kisicki

4

0 references

Horst Schran

The Journal of Clinical Pharmacology

5

0 references

language of work or name

English

0 references

publication date

June 2008

0 references

published in

0 references

volume

48

0 references

issue

6

0 references

page(s)

763-75

0 references

cites work

Protein kinase C activation and the development of diabetic complications

1 reference

https://api.crossref.org/works/10.1177%2F0091270008318006

A derivative of staurosporine (CGP 41 251) shows selectivity for protein kinase C inhibition and in vitro anti-proliferative as well as in vivo anti-tumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008318006

Inhibition of mutant FLT3 receptors in leukemia cells by the small molecule tyrosine kinase inhibitor PKC412.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008318006

Patients with acute myeloid leukemia and an activating mutation in FLT3 respond to a small-molecule FLT3 tyrosine kinase inhibitor, PKC412.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008318006

Upregulation of the vascular endothelial growth factor/vascular endothelial growth factor receptor system in experimental background diabetic retinopathy of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008318006

Vascular endothelial growth factor and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008318006

Dramatic inhibition of retinal and choroidal neovascularization by oral administration of a kinase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008318006

The kinase inhibitor PKC412 suppresses epiretinal membrane formation and retinal detachment in mice with proliferative retinopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008318006

Reduction of diabetic macular edema by oral administration of the kinase inhibitor PKC412.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008318006

Phase I and pharmacokinetic study of PKC412, an inhibitor of protein kinase C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008318006

Plasma inhibitory activity (PIA): a pharmacodynamic assay reveals insights into the basis for cytotoxic response to FLT3 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008318006

Transport proteins and intestinal metabolism: P-glycoprotein and cytochrome P4503A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008318006

Transporter-Enzyme Interactions: Implications for Predicting Drug-Drug Interactions from In Vitro Data

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270008318006

21 January 2018

Identifiers

DOI

10.1177/0091270008318006

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

18508951

1 reference

Consolidated OpenCitations Corpus – April 2017